While the FDA’s approval of the first ketamine-based drug for treatment-resistant depression is encouraging, there are still a lot of details to work out, says Cristina Cusin, MD.
Three recent studies from researchers at Massachusetts General Hospital that look at the connections between sleep and health.
Photo Filters Spark the Need for a Guide to Help Cosmetic Surgeons Recognize Body Dysmorphic Disorder
While flipping through filters can be a fun way to kill time or lighten a mood, researchers are beginning to find the way they artificially alter appearances might have negative consequences.
A research project led by Massachusetts General Hospital’s Deepak Vijaya Kumar, PhD, will seek to untangle the connections between microbes in the gut and the onset of Alzheimer’s disease.
The month of March is Women’s History Month, and every year on March 8th we recognize International Women’s Day to celebrate the achievements of women, support gender equality and raise awareness against gender bias.
Researchers at Massachusetts General Hospital have been collaborating on a grassroots campaign to increase the appointment rates of pediatric emergency care coordinators in Massachusetts emergency departments.
Researchers at Massachusetts General Hospital recently conducted a study to identify the factors that contribute to emotional stress after stroke, identify tools and strategies that would provide the most help, and determine an effective timeline and delivery system for an intervention program aimed at preventing chronic depression, anxiety and post traumatic stress in this high risk population.
Rare diseases can be very complex to treat due to lack of understanding, little to no options for treatment and limited funding. But it is for these reasons that raising awareness and supporting research and funding for rare diseases is so important. In honor of Rare Disease Day this year, we are highlighting a rare disease called neuromyelitis optica (NMO).
How a Dedicated Mass General Team Became the First to Discover Circulating Brain Tumor Cells in the Blood
Mass General researchers Shannon Stott and Brian Nahed have been working together for 10 years, and used their different backgrounds to their advantage to be the first to identify circulating brain tumor cells in the blood.